Bridge Medical
About Bridge Medical
Bridge Medical is a Technology company founded in 2011, and was acquired by Red Nucleus in February 2026. Evidence and outcomes research services are offered by Bridge Medical for biopharmaceutical companies. It operates in the Technology and Healthcare sectors. Bridge Medical offers products and services including Evidence Review & Synthesis and Value Evidence Planning. Its focus areas include Artificial Intelligence, AI in Research, Data Processing and Biopharmaceutical Services.
Company details
Bridge Medical is recognized as a partner for evidence and outcomes research, having been established in 2011 to support global biopharmaceutical teams. Services such as evidence review, synthesis, and AI integration are utilized across therapeutic areas to transform data into insights for regulators, payers, clinicians, and patients. Health economic modeling and value communications are employed to address barriers in medicine access, ensuring meaningful evidence drives change. Collaboration with experts is emphasized to enhance decision-making processes.
- Stage Acquired
- SectorsTechnologyHealthcare
- Website bridgemedical.org
- Social LinkedIn
- Acquired by Red Nucleus (Feb 2026)
- Legal Name Bridge Medical
- Investors
- Acquired byRed Nucleus
(Feb 2026)
Products & Services of Bridge Medical
Bridge Medical offers a comprehensive portfolio of products and services, including Evidence Review & Synthesis and Value Evidence Planning.
Evidence is reviewed and synthesized by Bridge Medical to facilitate decision-making and communication for stakeholders.
Value evidence plans are developed by Bridge Medical in collaboration with global teams to deliver insights for decision makers.
Investors in Bridge Medical
Bridge Medical has secured backing from 1 investor. Prominent investors backing the company include Red Nucleus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | 2014 | rednucleus.com | Yardley, United States |
Investor details for Bridge Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bridge Medical
2 dated milestones of Bridge Medical across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Bridge Medical is founded.
- Exit Acquired by Red Nucleus.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bridge Medical
Bridge Medical was founded in 2011.
Bridge Medical is recognized as a partner for evidence and outcomes research, having been established in 2011 to support global biopharmaceutical teams. Services such as evidence review, synthesis, and AI integration are utilized across therapeutic areas to transform data into insights for regulators, payers, clinicians, and patients. Health economic modeling and value communications are employed to address barriers in medicine access, ensuring meaningful evidence drives change. Collaboration with experts is emphasized to enhance decision-making processes.
Bridge Medical offers Evidence Review & Synthesis and Value Evidence Planning.
Bridge Medical has 1 investor. Key investors include Red Nucleus.
Bridge Medical operates through Bridge Medical.
Yes. Bridge Medical was acquired by Red Nucleus in February 2026.